Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Fish and Richardson
AstraZeneca
Citi
Cantor Fitzgerald
Accenture
Cerilliant
Healthtrust
Deloitte
Teva

Generated: December 12, 2017

DrugPatentWatch Database Preview

Repaglinide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for repaglinide and what is the scope of repaglinide freedom to operate?

Repaglinide
is the generic ingredient in two branded drugs marketed by Gemini Labs Llc, Actavis Totowa, Aurobindo Pharma Ltd, Boscogen, Mylan Pharms Inc, Paddock Llc, Sandoz Inc, and Sun Pharm Inds Inc, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for repaglinide. Seventeen suppliers are listed for this compound.

Pharmacology for repaglinide

Drug ClassGlinide
Mechanism of ActionPotassium Channel Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Actavis TotowaREPAGLINIDErepaglinideTABLET;ORAL090008-003Jan 22, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds IncREPAGLINIDErepaglinideTABLET;ORAL077571-003Jul 11, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Gemini Labs LlcPRANDINrepaglinideTABLET;ORAL020741-002Dec 22, 1997ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdREPAGLINIDErepaglinideTABLET;ORAL203820-003Jan 22, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Gemini Labs LlcPRANDINrepaglinideTABLET;ORAL020741-003Dec 22, 1997ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncREPAGLINIDErepaglinideTABLET;ORAL090252-001Aug 23, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds IncREPAGLINIDErepaglinideTABLET;ORAL077571-002Jul 11, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BoscogenREPAGLINIDErepaglinideTABLET;ORAL091517-003Apr 24, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Paddock LlcREPAGLINIDErepaglinideTABLET;ORAL201189-001Jul 17, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Gemini Labs LlcPRANDINrepaglinideTABLET;ORAL020741-001Dec 22, 1997ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: repaglinide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gemini Labs LlcPRANDINrepaglinideTABLET;ORAL020741-002Dec 22, 1997► Subscribe► Subscribe
Gemini Labs LlcPRANDINrepaglinideTABLET;ORAL020741-003Dec 22, 1997► Subscribe► Subscribe
Gemini Labs LlcPRANDINrepaglinideTABLET;ORAL020741-003Dec 22, 1997► Subscribe► Subscribe
Gemini Labs LlcPRANDINrepaglinideTABLET;ORAL020741-001Dec 22, 1997► Subscribe► Subscribe
Gemini Labs LlcPRANDINrepaglinideTABLET;ORAL020741-002Dec 22, 1997► Subscribe► Subscribe
Gemini Labs LlcPRANDINrepaglinideTABLET;ORAL020741-003Dec 22, 1997► Subscribe► Subscribe
Gemini Labs LlcPRANDINrepaglinideTABLET;ORAL020741-002Dec 22, 1997► Subscribe► Subscribe
Gemini Labs LlcPRANDINrepaglinideTABLET;ORAL020741-002Dec 22, 1997► Subscribe► Subscribe
Gemini Labs LlcPRANDINrepaglinideTABLET;ORAL020741-001Dec 22, 1997► Subscribe► Subscribe
Gemini Labs LlcPRANDINrepaglinideTABLET;ORAL020741-002Dec 22, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Dow
Express Scripts
Cipla
UBS
Healthtrust
Argus Health
Queensland Health
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot